Trend Watch



Friday, September 16, 2011


Baraka,the only pharmaceutical standard designed Food Supplement with Nigella Sativa Oil Extract to maintain good health.

Many centuries ago , Nigella Sativa ,or black cumin, or known as Habbatus-Sauda is regarded by many as a panacea for many illness. Habbatus-Sauda seeds have been known to have the high remedial quality. Remedy asthma and allergies, and also banish fatigue.

Baraka is a pharmaceutical quality product with endorsement of Ministry of Health Malaysia and NPCB.

Each capsule contains: Nigella Sativia Oil Extract 450mg

Usage: 2 to 6 capsules daily.

{Sabda Prophet Muhammad S.A.W,"Keep your treatment with Habbatus-Sabda, as it contains a cure for all illnesses except death" ,related by Al-Bukhari.}

Nigella sativa oil (not black cumin seed oil) contains nigellone, which protects guinea pigs from histamine-induced bronchial spasms(perhaps explaining its use to relieve the symptoms of asthma, bronchitis, and coughing).
The presence of an antitumor sterol, beta-sitosterol, lends credence to its traditional use to treat abscesses and tumors of the abdomen, eyes, and liver.
N. sativa oil has been reported to be effective in treating opioid dependence.
N. sativa also has been reported to reduce calculi formation in rats' kidneys.
The oil contains melanthin, nigilline, damascene and tannin. Melanthin is toxic in large doses and nigelline is paralytic, so this spice must be used in moderation.

Researchers at the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia have found that thymoquinone, an extract of N. sativa seed oil, blocked pancreatic cancer cell growth and killed the cells by enhancing the process of programmed cell death, (apoptosis), acting as an HDAC inhibitor. While the studies are in the early stages, the findings suggest thymoquinone could eventually have some use as a preventative strategy in patients who have gone through surgery and chemotherapy or in individuals who are at a high risk of developing cancer.

Nigella Sativa currently has five (5) FDA separate patents in the U.S. and one (1) in the UK for the treatment of:
1.Diabetes (US 6,042,834)

2.Inhibition of cancer cell growth (US 5,653,981)

3.Improvement of the Immune System (US 5,482,711)

4.Viral Infections (US 6,841,174)

5.Psoriasis (US 6,531,164)

6.Asthma (UK - EP1709995)

No comments: